The free-to-total serum prostatic specific antigen ratio as a predictor of the pathological features of prostate cancer

被引：0

作者：

Erdem E. ^{[1
]}

Atsü N. ^{[1
]}

Akbal C. ^{[1
]}

Bilen C.Y. ^{[1
]}

Ergen A. ^{[1
]}

Özen H. ^{[1
]}

机构：

[1] Hacettepe University, Medical Faculty, Department of Urology

来源：

International Urology and Nephrology | 2002年 / 34卷 / 4期

关键词：

Free to Total PSA ratio; Pathological features; Prostate cancer;

D O I：

10.1023/A:1025685718493

中图分类号：

学科分类号：

摘要：

Objectives: Curative therapy and extended period of disease free survival for patients with prostate cancer is possible only if the radical prostatectomy is performed when the disease is organ confined. It has been shown that combined use of local clinical stage, Gleason score of transrectal needle biopsy and serum PSA can accurately predict the final pathological stage in men undergoing radical prostatectomy. Recently the free/total PSA (F/T PSA) has been shown to improve the specificity of serum PSA level in early detection prostate cancer. In this study the utility of F/T PSA ratio in prediction the final pathological features of the prostate cancer was investigated. Methods: 52 patients who had undergone radical prostatectomy were included in this study with mean age of 63 (ranging from 49 to 73). According to the pathologic features of the tumors, patients were classified as organ confined in 37 (%71), specimen-confined in 39 (%75) and as with favorable pathology which was defined as organ confined or specimen confined with Gleason score lower than 7, 39 (%75) patients. Results: Neither total PSA levels nor F/T PSA values correlate significantly with the pathological characteristics of the tumor. The logistic regression analysis showed that the biopsy Gleason score was the only variable that was able to predict the pathology of the tumor (p < 0,05). Conclusion: As a conclusion Gleason score of the needle biopsy specimen is the most predictive factor of the final pathological outcome. F/T PSA ratio did not provide additional information about predicting pathological stage.

引用

页码：519 / 523

页数：4

共 17 条

[1]

Ackerman D.A., Barry J.M., Wicklend R.A., Et al., Analysis risk factors associated with prostate cancer extension to the surgical margin and pelvic lymph node metastasis at radical prostatectomy, J Urol, 150, pp. 1845-1850, (1993)

[2]

Arcengeli C.G., Shepherd L., Smith D.S., Et al., Correlation of percent free PSA with pathologic features of prostatic carcinoma, J Urol, 155, (1996)

[3]

Blackwell K.L., Bosstwick D.G., Myers R.P., Et al., Combining prostate specific antigen with cancer and gland volume to predict more reably pathological stage: The influence of prostate specific antigen density, J Urol, 151, pp. 1565-1570, (1994)

[4]

Blustein D.L., Bostwick D.G., Bergralh E.J., Oesterling J.E., Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer, J Urol, 151, pp. 1315-1320, (1994)

[5]

Bostwick D.G., Quin J., Bergstralh E., Et al., Prediction of capsular perforation and seminal vesicul invasion in prostate cancer, J Urol, 155, pp. 1361-1367, (1996)

[6]

Firat D., Hayran M., Cancer Statistics in Turkey and in the World (1990-1992). 1st Edition, pp. 16-41, (1995)

[7]

Graefen M., Hammerer P., Henke P., Et al., Percentage of free PSA does not correlate with pathological outcome, J Urol, 155, (1996)

[8]

Henricks W.H., England B.G., Donald A., Et al., Free to total PSA ratio does not predict extraprostatic spread of prostatic adenocarcinoma, J Urol, 155, (1996)

[9]

Morete J., Encabo M.A., Lopez M.A., De Torres I.M., The free to total serum prostatic specific antigen ratio as a predictor of the pathological features of prostate cancer, BJU Int, 83, pp. 1003-1006, (1999)

[10]

Narayan P., Fournier G., Gajandren V., Et al., Utility of preoperative serum prostate specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer, Urology, 44, pp. 519-524, (1994)

← 1 2 →